D. Toppmeyer
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- PARP inhibition in cancer therapy
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
- Cancer Research top 5%
- Breast Cancer Treatment Studies
Papers in
-
- Breast Cancer Treatment Studies 2
- Cancer Genomics and Diagnostics 1
- Oncology 2
- Cancer Immunotherapy and Biomarkers 1
- HER2/EGFR in Cancer Research 1
- Co-authors
- Gyan Bhanot (1 shared paper)Erhan Bilal (1 shared paper)Ming Yao (1 shared paper)Vasudeva Ginjala (1 shared paper)Gabriela Alexe (1 shared paper)Jean A. McDougall (1 shared paper)Anya M. Litvak (1 shared paper)Nusayba Ali Bagegni (1 shared paper)
- Journals
- ESMO Open (2 papers)Cancer Epidemiology Biomarkers & Prevention (1 paper)Annals of Oncology (1 paper)Genes & Cancer (1 paper)
- Partner nations
- United States
In The Last Decade
D. Toppmeyer
4 papers receiving 694 citations
D. Toppmeyer's Hit Papers
Peers
Comparison fields: 5 of 41
- Oncology 460
- Cancer Research 257
- Immunology 44
- Pulmonary and Respiratory Medicine 37
- Pathology and Forensic Medicine 14
Countries citing papers authored by D. Toppmeyer
This map shows the geographic impact of D. Toppmeyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Toppmeyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Toppmeyer more than expected).
Fields of papers citing papers by D. Toppmeyer
This network shows the impact of papers produced by D. Toppmeyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Toppmeyer. The network helps show where D. Toppmeyer may publish in the future.
Co-authors
The 19 scholars most cited alongside D. Toppmeyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study Hit paper breakdown → | 2018 | 681 |
| 2 | 2010 | 29 | |
| 3 | 2022 | 1 | |
| 4 | 2023 | 1 | |
| 5 | 2026 | 0 |
About D. Toppmeyer
D. Toppmeyer is a scholar working on Cancer Research, Oncology, Genetics, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 5 papers that have together received 712 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (2 papers), Cancer Immunotherapy and Biomarkers (1 paper), Cancer Genomics and Diagnostics (1 paper), HER2/EGFR in Cancer Research (1 paper) and BRCA gene mutations in cancer (1 paper). The work is most often cited by research in Oncology (460 citations), Cancer Research (257 citations), Immunology (44 citations), Pulmonary and Respiratory Medicine (37 citations) and Pathology and Forensic Medicine (14 citations). D. Toppmeyer has collaborated with scholars based in United States. Frequent co-authors include Gyan Bhanot, Erhan Bilal, Ming Yao, Vasudeva Ginjala, Gabriela Alexe, Jean A. McDougall, Anya M. Litvak, Nusayba Ali Bagegni, Salma K. Jabbour and Ekaterina V. Kalashnikova. Their work appears in journals such as ESMO Open, Cancer Epidemiology Biomarkers & Prevention, Annals of Oncology and Genes & Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.